Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,961 Cr
up ₹49.4 Cr vs Apr 2025
- Stocks held
- 30
- unchanged
- Top 10 weight
- 62.1%
- of the portfolio in its ten largest
- Cash & debt
- 0.4%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 10
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In May 2025 it disclosed 30 stocks worth ₹2,961 Cr, up ₹49.4 Cr from Apr 2025. Its largest positions were Cipla Limited (8.9%), Suven Pharmaceuticals Limited (8.8%), Sun Pharmaceutical Industries Limited (8.7%); the ten largest together made up 62.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 66.9% of its equity. Cash and debt stood at 0.4%. Compared with Apr 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
6%
Holds more cash than 6% of peers
Holdings in May 2025
Download CSVEvery line the fund disclosed, with the change against Apr 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.86%
- Δ weight
- down 0.67 pts
- Value
- ₹262 Cr
- Δ value
- down ₹15.1 Cr
- Status
- Trimmed
- Weight
- 8.81%
- Δ weight
- down 0.91 pts
- Value
- ₹261 Cr
- Δ value
- down ₹22.3 Cr
- Status
- Trimmed
- Weight
- 8.70%
- Δ weight
- down 0.96 pts
- Value
- ₹258 Cr
- Δ value
- down ₹23.8 Cr
- Status
- Trimmed
- Weight
- 8.16%
- Δ weight
- down <0.01 pts
- Value
- ₹242 Cr
- Δ value
- up ₹4 Cr
- Status
- Added
- Weight
- 4.94%
- Δ weight
- up 0.51 pts
- Value
- ₹146 Cr
- Δ value
- up ₹17.4 Cr
- Status
- Added
- Weight
- 4.91%
- Δ weight
- up 0.62 pts
- Value
- ₹145 Cr
- Δ value
- up ₹20.4 Cr
- Status
- Added
- Weight
- 4.59%
- Δ weight
- down 1.04 pts
- Value
- ₹136 Cr
- Δ value
- down ₹28.1 Cr
- Status
- Trimmed
- Weight
- 4.57%
- Δ weight
- down 0.03 pts
- Value
- ₹135 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 4.53%
- Δ weight
- down 0.14 pts
- Value
- ₹134 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 4.08%
- Δ weight
- up 0.26 pts
- Value
- ₹121 Cr
- Δ value
- up ₹9.6 Cr
- Status
- Added
- Weight
- 3.81%
- Δ weight
- up 0.17 pts
- Value
- ₹113 Cr
- Δ value
- up ₹6.9 Cr
- Status
- Added
- Weight
- 3.80%
- Δ weight
- up 0.85 pts
- Value
- ₹113 Cr
- Δ value
- up ₹26.5 Cr
- Status
- Added
- Weight
- 3.45%
- Δ weight
- up 0.29 pts
- Value
- ₹102 Cr
- Δ value
- up ₹10.3 Cr
- Status
- Added
- Weight
- 3.08%
- Δ weight
- up 0.31 pts
- Value
- ₹91.2 Cr
- Δ value
- up ₹10.6 Cr
- Status
- Added
- Weight
- 3.02%
- Δ weight
- down 0.19 pts
- Value
- ₹89.5 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Weight
- 2.99%
- Δ weight
- up 0.16 pts
- Value
- ₹88.6 Cr
- Δ value
- up ₹6.3 Cr
- Status
- Added
- Weight
- 2.89%
- Δ weight
- up 0.34 pts
- Value
- ₹85.6 Cr
- Δ value
- up ₹11.3 Cr
- Status
- Added
- Weight
- 2.74%
- Δ weight
- up 0.15 pts
- Value
- ₹81.1 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 1.72%
- Δ weight
- down 0.04 pts
- Value
- ₹51 Cr
- Δ value
- down ₹36 L
- Status
- Trimmed
- Weight
- 1.54%
- Δ weight
- up 0.34 pts
- Value
- ₹45.6 Cr
- Δ value
- up ₹10.6 Cr
- Status
- Added
- Weight
- 1.53%
- Δ weight
- down 0.03 pts
- Value
- ₹45.3 Cr
- Δ value
- down ₹3 L
- Status
- Held
- Weight
- 1.28%
- Δ weight
- up 0.26 pts
- Value
- ₹37.8 Cr
- Δ value
- up ₹8.1 Cr
- Status
- Added
- Weight
- 1.22%
- Δ weight
- up 0.01 pts
- Value
- ₹36.1 Cr
- Δ value
- up ₹94 L
- Status
- Added
- Weight
- 0.82%
- Δ weight
- down 0.69 pts
- Value
- ₹24.1 Cr
- Δ value
- down ₹19.6 Cr
- Status
- Trimmed
- Weight
- 0.81%
- Δ weight
- up 0.12 pts
- Value
- ₹24 Cr
- Δ value
- up ₹3.9 Cr
- Status
- Added
- Weight
- 0.64%
- Δ weight
- down 0.01 pts
- Value
- ₹19 Cr
- Δ value
- down ₹7 L
- Status
- Held
- Weight
- 0.63%
- Δ weight
- up 0.10 pts
- Value
- ₹18.6 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.55%
- Δ weight
- down 0.04 pts
- Value
- ₹16.3 Cr
- Δ value
- down ₹80 L
- Status
- Trimmed
- Weight
- 0.47%
- Δ weight
- down 0.01 pts
- Value
- ₹13.8 Cr
- Δ value
- down ₹3 L
- Status
- Held
- Cash, TREPS & receivables
- Weight
- 0.42%
- Δ weight
- up 0.29 pts
- Value
- ₹12.4 Cr
- Δ value
- up ₹8.6 Cr
- Status
- Added
- Weight
- 0.36%
- Δ weight
- down 0.01 pts
- Value
- ₹10.8 Cr
- Δ value
- down ₹22 L
- Status
- Trimmed
- Weight
- 0.10%
- Δ weight
- up 0.01 pts
- Value
- ₹2.9 Cr
- Δ value
- up ₹30 L
- Status
- Added
What changed, Apr 2025 to May 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Pfizer Limitedup ₹26.5 Cr (+0.85% pts)
- Alembic Pharmaceuticals Limitedup ₹20.4 Cr (+0.62% pts)
- Gland Pharma Limitedup ₹17.4 Cr (+0.51% pts)
- Concord Biotech Limitedup ₹11.3 Cr (+0.34% pts)
- Procter & Gamble Health Limitedup ₹10.6 Cr (+0.31% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2025, the weight rose most in Pharmaceuticals & Biotechnology (+1.1 pts) and Pharmaceuticals (+0.1 pts), and fell most in Healthcare Equipment & Supplies (−0.9 pts) and Healthcare Services (−0.4 pts).
- Pharmaceuticals & Biotechnology65.9% → 66.9%+1.1 pts
- Pharmaceuticals5.6% → 5.7%+0.1 pts
- Healthcare Equipment & Supplies8.9% → 8.0%−0.9 pts
- Healthcare Services17.6% → 17.2%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2022 | May 2024 | Nov 2024 | Feb 2025 | Apr 2025 | May 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 56.3% | 68.5% | 64.2% | 65.2% | 65.9% | 66.9% |
| Healthcare Services | 26.4% | 15.3% | 18.3% | 17.5% | 17.6% | 17.2% |
| Healthcare Equipment & Supplies | 5.8% | 8.3% | 9.1% | 10.1% | 8.9% | 8.0% |
| Pharmaceuticals | 7.3% | 5.6% | 6.4% | 5.3% | 5.6% | 5.7% |
| Insurance | 2.6% | 1.7% | 1.5% | 1.4% | 1.6% | 1.5% |
| Retailing | 1.4% | 0.6% | 0.5% | 0.5% | 0.5% | 0.6% |
Allocation in May 2025change vs Apr 2025
- Pharmaceuticals & Biotechnology (14)66.9%▲ 1.1 pts
- Healthcare Services (8)17.2%▼ 0.4 pts
- Healthcare Equipment & Supplies (3)8.0%▼ 0.9 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, May 2025
0.4%
▲ 0.3 pts vs Apr 2025
- Cash alone
- 0.4%
- cash and net receivables
- A year earlier
- 1.3%
- May 2024 · now ▼ 0.9 pts
- Last 12 months
- 0.1% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.